0000899243-22-019969.txt : 20220527
0000899243-22-019969.hdr.sgml : 20220527
20220527174956
ACCESSION NUMBER: 0000899243-22-019969
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220525
FILED AS OF DATE: 20220527
DATE AS OF CHANGE: 20220527
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Auerbach Michael
CENTRAL INDEX KEY: 0001746080
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40493
FILM NUMBER: 22979421
MAIL ADDRESS:
STREET 1: 158 HESTER STREET
STREET 2: APT 7F
CITY: NEW YORK
STATE: NY
ZIP: 10013
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ATAI Life Sciences N.V.
CENTRAL INDEX KEY: 0001840904
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 180 VARICK STREET
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: (617) 699-5876
MAIL ADDRESS:
STREET 1: 180 VARICK STREET
CITY: NEW YORK
STATE: NY
ZIP: 10014
FORMER COMPANY:
FORMER CONFORMED NAME: ATAI Life Sciences B.V.
DATE OF NAME CHANGE: 20210115
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-25
0
0001840904
ATAI Life Sciences N.V.
ATAI
0001746080
Auerbach Michael
C/O SUBVERSIVE ATAI, LLC,
217 CENTRE STREET, SUITE 122
NEW YORK
NY
10013
1
0
0
0
Stock Option
3.84
2022-05-25
4
A
0
64000
0.00
A
2032-05-25
Common Shares
64000
64000
D
The stock option shall vest on the earlier of the day before ATAI Life Sciences N.V.'s next annual meeting or May 25, 2023.
/s/ Ryan Barrett, Attorney-in-fact
2022-05-27